Ablatus awarded £1M Innovate UK grant

We are delighted to have been awarded over £1M by the UK government to develop our novel minimally invasive treatment for soft tissue tumours.  The award will fund a 2-year project to develop the protype device into a final version for use in patients for the first time. Partnering with Cambridge-based product engineering and design […]

Ablatus Therapeutics receives first CE Mark for Bimodal Electric Tissue Ablation system component

We are delighted to announce that we have received our first CE mark! Our surgical ablation system offers significant advantage over the current standard of care across a variety of therapeutic indications. One of the components of the system is a patient grounding pad which facilitates energy delivery into the targeted tissue. The CE Mark […]

Ablatus Therapeutics achieves ISO 13485:2016 certification

Ablatus has been certified to ISO 13485:2016 following successful audits with BSI. ISO 13485 is a global standard in quality management systems for medical devices that supports polices and processes across the entire business. CEO David Brooks said: “As we continue development of our technology for clinical use, conforming to the ISO 13485 standard is […]

Ablatus reaches final of east of England Investment Catalyst Pitching Day

We are delighted to announce that David Brooks, our CEO, successfully pitched to a panel of investors on 31st October and won a spot at the prestigious final of the East of England Investment Catalyst Pitching Day. David saw off stiff competition from 10 other companies from the Cambridge area and now benefits bespoke support […]

Article in Medical Technology

We are delighted to be in print in issue 18 of Medical Technology. The article is entitled ‘Destroying tumours with next-generation ablation’, here’s brief intro, click here to read the full article. “Radiofrequency ablation (RFA) can destroy solid tumours without the need for invasive surgery. At the forefront is NHS Norfolk and Norwich University Hospital […]

Healthcare revolution: The ten health innovations that could soon be on the NHS

In the 70 years since the NHS was established, medical breakthroughs such as MRI scanners, IVF and dialysis machines have transformed the health service and people’s lives. And while it’s impossible to predict how things will change over the next seven decades experts such as NHS England’s health innovation chief Professor Tony Young are predicting […]

Award nomination for New Anglia Capital investee Ablatus

Norfolk and Norwich University Hospital spin-out Ablatus Therapeutics has been shortlisted for the esteemed UK Business Angels Association (UKBAA) Angel Investment Awards. The awards will celebrate 2018’s high-growth entrepreneur success stories and the investors behind them and will be presented at a glittering ceremony on 19th June, in Liverpool Cathedral. Ablation uses heat generated by electric […]

Breaking down the barriers

Despite the Governments recent Accelerated Access Review – barriers to adoption of new technology in the NHS is still stifling medical innovation. We need a mind-set change says Dr Anne Blackwood. For many onlookers, curing cancer is one of medical research’s holy grails – a top-level goal that has been in the crosshairs for decades and […]

NVM Private Equity leads investment in Ablatus Therapeutics

NVM Private Equity (“NVM”) has invested £1.0 million of growth capital into Cambridge-based medical device company Ablatus Therapeutics Limited (“Ablatus”) alongside existing angel investors. Ablatus was founded in 2016 as a spin out from the NHS, under the guidance of Health Enterprise East (HEE), to develop and commercialise patented Bimodal Electric Tissue Ablation (BETA) technology. […]

East Anglia’s angel investor fund has been given a £1m top-up to support young businesses

A venture capital fund backing some of the region’s high-growth business prospects has received a million-pound top-up to invest in more start-ups. The funding for New Anglia Local Enterprise Partnership’s angel investment programme New Anglia Capital (NAC) means that the LEP has now allocated £3m to the project. NAC is a co-investment fund with New […]